Aprepitant EP Impurity C |
阿瑞匹坦EP杂质C |
2348441-63-2 |
Aprepitant EP Impurity B |
阿瑞匹坦EP杂质B |
2348441-62-1 |
N-Depiperidin-3-amine Linagliptin Dimer |
N-Depiperidin-3-amine Linagliptin Dimer |
2253964-98-4 |
Vonoprazan Fumarate Impurity 6 |
Vonoprazan Fumarate Impurity 6 |
2250243-23-1 |
Linagliptin Impurity 28 |
Linagliptin Impurity 28 |
2074688-84-7 |
Linagliptin Impurity 38 |
Linagliptin Impurity 38 |
1979144-52-9 |
4-((1-((6-cyano-5-(trifluoromethyl)pyridin-3-yl)carbamoyl)cyclobutyl)amino)-2-fluoro-N-methylbenzamide |
4-((1-((6-cyano-5-(trifluoromethyl)pyridin-3-yl)carbamoyl)cyclobutyl)amino)-2-fluoro-N-methylbenzamide |
1950587-20-8 |
Obeticholic Acid Impurity 32 |
奥贝胆酸杂质32 |
1831863-02-5 |
1627504-43-1 |
1627504-43-1 |
1627504-43-1 |
PropanaMide, N-[2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]- |
(Z)-N-(2-(6,7-二氢-1H-茚并[5,4-B]呋喃-8(2H) - 亚基)乙基)丙酰胺 |
1365920-11-1 |
Apalutamide Acid Impurity |
Apalutamide Acid Impurity |
1332391-04-4 |
5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide |
培唑帕尼杂质 |
1252927-47-1 |
Pazopanib Impurity 8 |
Pazopanib Impurity 8 |
1226500-00-0 |
PropanaMide, N-[2-(1,6-dihydro-2H-indeno[5,4-b]furan-8-yl)ethyl]- |
N-(2-(1,6-DIHYDRO-2H-INDENO[5,4-B]FURAN-8-YL)ETHYL)PROPIOMIDE |
196597-30-5 |
Regorafenib Impurity 9 |
Regorafenib Impurity 9 |
2188236-16-8 |
4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-6,8-dioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluoro-N-methylbenzamide |
4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-6,8-dioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluoro-N-methylbenzamide |
1332391-92-0 |
N-desmethyl?Apalutamide |
ARN-509 杂质 |
1332391-11-3 |
Maleic Acid |
Maleic Acid |
2170020-79-6 |
Linagliptin MethyldiMer |
LINAGLIPTIN METHYLDIMER |
1418133-47-7 |
Obeticholic Acid Impurity 2 |
奥贝胆酸杂质2 |
915038-27-6 |